Having trouble accessing articles? Reset your cache.

FDA to require label update for GnRH agonists

FDA will require manufacturers to update the labels for gonadotropin-releasing hormone (GnRH) agonists

Read the full 139 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE